Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 An integrated approach to the pharmacokinetic analysis of drug absorption.

Literature DB >> 4461782

An integrated approach to the pharmacokinetic analysis of drug absorption.

A E Till, L Z Benet, K C Kwan.

Abstract

Mesh：

Substances：

Year: 1974 PMID： 4461782 DOI： 10.1007/BF01070946

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

7 in total

1. Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors: J G WAGNER; E NELSON
Journal: J Pharm Sci Date: 1963-06 Impact factor: 3.534

2. Novel method for bioavailability assessment.

Authors: K C Kwan; A E Till
Journal: J Pharm Sci Date: 1973-09 Impact factor: 3.534

3. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors: L Z Benet
Journal: J Pharm Sci Date: 1972-04 Impact factor: 3.534

4. Pharmacokinetics of phosphonomycin in Man. I. Intravenous administration.

Authors: K C Kwan; D A Wadke; E L Foltz
Journal: J Pharm Sci Date: 1971-05 Impact factor: 3.534

5. Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors: S Riegelman; J C Loo; M Rowland
Journal: J Pharm Sci Date: 1968-01 Impact factor: 3.534

6. New method for calculating the intrinsic absorption rate of drugs.

Authors: J C Loo; S Riegelman
Journal: J Pharm Sci Date: 1968-06 Impact factor: 3.534

7. Estimation of volume of distribution and half-life of a compound after rapid intravenous injection.

Authors: J G Wagner; J I Northam
Journal: J Pharm Sci Date: 1967-04 Impact factor: 3.534

7 in total

11 in total

1. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.

Authors: H Stass; M F Böttcher; K Ochmann
Journal: Clin Pharmacokinet Date: 2001 Impact factor: 6.447

2. Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Authors: H Boxenbaum
Journal: Pharm Res Date: 1984-03 Impact factor: 4.200

3. Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.

Authors: K C Kwan; G O Breault; E R Umbenhauer; F G McMahon; D E Duggan
Journal: J Pharmacokinet Biopharm Date: 1976-06

4. Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.

Authors: M O Karlsson; U Bredberg
Journal: J Pharmacokinet Biopharm Date: 1990-04

5. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors: H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal: J Pharmacokinet Biopharm Date: 1977-02

6. Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.

Authors: K C Kwan; G O Breault; R L Davis; B W Lei; A W Czerwinski; G H Besselaar; D E Duggan
Journal: J Pharmacokinet Biopharm Date: 1978-12

7. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors: W L Chiou
Journal: J Pharmacokinet Biopharm Date: 1978-12